ARL BIO PHARMA H-1B Visa Sponsorship & Salary Data

The median H-1B salary at ARL BIO PHARMA is $67,808, based on 29 certified filings from FY 2022 to FY 2026. This is 43% lower than the national H-1B median salary of $120,000. Compensation at ARL BIO PHARMA reflects their market positioning, with entry-level roles starting around $58,240 and senior positions reaching $106,000 or higher. These figures represent base salaries in LCA filings and may not include bonuses, equity grants, or other compensation common at large employers.

Salaries at ARL BIO PHARMA range from $54,080 at the 10th percentile to $106,000 at the 90th percentile, showing a $51,920 spread across experience levels and roles. The 25th percentile is $58,240 and the 75th percentile is $80,000.

Yes, ARL BIO PHARMA actively sponsors H-1B visas and has been a consistent participant in the H-1B program. They have filed 29 H-1B labor condition applications from FY 2022 to FY 2026, demonstrating ongoing commitment to hiring international talent. With 29 certified applications and a 0% denial rate, ARL BIO PHARMA maintains a strong track record for H-1B sponsorship. The company sponsors positions across multiple job categories and locations, making them a viable option for professionals seeking H-1B visa sponsorship.

In the most recent fiscal year (FY 2026), ARL BIO PHARMA filed 2 H-1B applications, with 2 certified and 0 denied. Over 4 years of data, ARL BIO PHARMA has consistently demonstrated commitment to H-1B sponsorship.

Note: These are Labor Condition Applications (LCAs) filed with the Department of Labor, which is a prerequisite for H-1B petitions. The actual number of H-1B petitions filed with USCIS may differ.

ARL BIO PHARMA's LCA (Labor Condition Application) denial rate is 0%, with 0 out of 29 applications denied across all years. This translates to a 100.0% certification rate, which indicates how successfully the company prepares and files H-1B applications. A lower denial rate suggests better compliance with Department of Labor requirements, proper wage documentation, and accurate job classification. Prospective H-1B applicants should consider this approval rate alongside other factors like salary, job role, and location when evaluating ARL BIO PHARMA as a potential H-1B sponsor.

This is an excellent approval rate, indicating ARL BIO PHARMA has strong H-1B sponsorship practices and typically meets DOL requirements. Applicants can feel confident in the company's H-1B track record.

ARL BIO PHARMA sponsors H-1B visas for various specialty occupation positions requiring at least a bachelor's degree. Based on 29 certified filings, the most commonly sponsored job titles reflect the company's primary business functions and talent needs. These positions typically require specialized knowledge in fields like technology, engineering, finance, or scientific research. Understanding which roles ARL BIO PHARMA most frequently sponsors can help job seekers target their applications effectively.

Most common H-1B job titles at ARL BIO PHARMA:

The most frequently sponsored role is Research Scientist II with 5 filings at a median salary of $61,090. This is followed by Project Manager II (5 filings) and Chemist II.

ARL BIO PHARMA's H-1B positions are distributed across multiple U.S. locations, with concentration in major metropolitan areas and tech hubs. Geographic distribution often reflects company office locations, client sites, and regional market demands. Location significantly impacts H-1B salary due to varying cost of living and local wage requirements. Understanding where ARL BIO PHARMA sponsors H-1B workers can help candidates target specific offices and negotiate appropriate compensation for each market.

Top ARL BIO PHARMA H-1B locations:

The largest H-1B hub for ARL BIO PHARMA is Oklahoma City, OK with 27 filings at a median salary of $64,459. The highest-paying location is Oklahoma, OK at $106,000 median. Salaries range from $64,459 to $106,000 across office locations.

ARL BIO PHARMA's median H-1B salary has increased by +29% from FY 2022 ($61,090) to FY 2026 ($79,040). Tracking salary trends over time reveals how ARL BIO PHARMA adjusts compensation to remain competitive in the H-1B labor market. Salary growth typically reflects inflation adjustments, increased demand for specialized skills, and evolving prevailing wage requirements. These historical trends can help applicants understand future salary expectations and negotiate appropriately when considering H-1B opportunities at ARL BIO PHARMA.

Year-by-year breakdown:

• FY 2022: $61,090 (4 certified)
• FY 2024: $88,192 (6 certified)
• FY 2025: $70,720 (17 certified)
• FY 2026: $79,040 (2 certified)

This 29% growth reflects strong compensation adjustments at ARL BIO PHARMA, keeping pace with market demands for H-1B talent.

ARL BIO PHARMA primarily files H-1B applications at Wage Level II, accounting for 66% of their filings. DOL wage levels range from Level I (entry-level, 17th percentile of local wages) to Level IV (expert, 67th percentile). Wage level determines both salary requirements and, under recent H-1B rules, lottery selection priority. Higher wage levels receive preference in the H-1B lottery, making ARL BIO PHARMA's wage level distribution an important factor for prospective applicants assessing their chances of H-1B selection.

ARL BIO PHARMA has a mix of entry-level (Level I) and experienced (Level II+) H-1B positions. This reflects a range of roles from junior to senior.

ARL BIO PHARMA's median H-1B salary of $67,808 is 43% lower than the national H-1B median of $120,000 across all employers and industries. This comparison provides context for evaluating ARL BIO PHARMA's competitiveness in attracting H-1B talent. Keep in mind that industry, location, and job function significantly impact salary levels. Tech companies and financial institutions typically offer higher H-1B salaries than other sectors, while salaries in major metros like San Francisco and New York exceed those in smaller markets. Compare ARL BIO PHARMA's offerings with similar companies in your field for a more accurate assessment.

ARL BIO PHARMA's H-1B salaries are below the national median, though this may vary significantly by role, experience level, and location. Consider researching specific positions for more accurate compensation expectations.

Recent H-1B rule changes have increased filing fees and introduced wage-level prioritization in the lottery. ARL BIO PHARMA files 21% of positions at Level I, which may face more lottery competition under wage-level prioritization rules.

With 29 certified filings, ARL BIO PHARMA invests significantly in H-1B sponsorship. The company's 0% denial rate suggests strong compliance with H-1B requirements and documentation standards.

Note: H-1B regulations are subject to change. Fees shown are estimates based on 2024 USCIS fee schedules. Actual costs may vary based on company size, premium processing, and future rule changes.